Home › Funds › Gem Investment Advisors, LLC › ORMP

Gem Investment Advisors, LLC position in ORMP

ORAMED PHARMACEUTICALS INC · Health Care

Gem Investment Advisors, LLC reported holding 1,998,802 shares of ORMP (ORAMED PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$9.3M, representing 6.73% of its reported portfolio and ranking #4 among its reported holdings. Gem Investment Advisors, LLC has disclosed ORMP holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)2.00M sh
Reported value held$9.33M
Portfolio Weight6.73%
First reportedQ4 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Gem Investment Advisors, LLC's ORMP position evolved

Gem Investment Advisors, LLC first disclosed a stake in ORMP in Q4 2025 at 1,998,802 shares (US$5.7M). The position peaked in Q2 2026 at 1,998,802 shares, worth US$9.6M. Across 4 filings, Gem Investment Advisors, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,998,802 shares valued at US$9.3M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 2.00M $5.70M New
Q1 2026 1.64M $5.58M Reduce
Q2 2026 2.00M $9.61M Add
Q3 2026 2.00M $9.33M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORMP and 13F data

ORMP (ORAMED PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in ORMP — the largest reported positions include Aquamarine Financial (Cayman) Ltd (US$12.4M), Murchinson Ltd. (US$10.0M), BML Capital Management, LLC (US$4.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORMP

All ORMP fund holders →

FAQ

How long has Gem Investment Advisors, LLC held ORMP?

Gem Investment Advisors, LLC has disclosed ORMP holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Gem Investment Advisors, LLC's current position in ORMP?

As of Q3 2026, Gem Investment Advisors, LLC holds 2.00M shares of ORMP (ORAMED PHARMACEUTICALS INC), valued at $9.33M, representing 6.73% of its reported portfolio and ranking #4.

Has Gem Investment Advisors, LLC been buying or selling ORMP?

In the latest 13F filing (Q3 2026), Gem Investment Advisors, LLC held unchanged its position in ORMP. The position peaked in Q2 2026 at 2.00M shares.

Which other funds hold ORMP?

Other major institutional holders of ORMP include Aquamarine Financial (Cayman) Ltd, Murchinson Ltd., BML Capital Management, LLC, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.